We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laser System Treats Enlarged Prostate

By HospiMedica staff writers
Posted on 31 May 2005
An enhanced version of the GreenLight laser system is designed for photoselective vaporization of the prostate (PVP), specifically for benign prostatic hyperplasia (BPH).

The GreenLight laser system has been re-engineered and integrated with new fiber-optic delivery devices to provide doctors with better performance through maximum fiber flexibility and control. More...
Faster system and set-up times and real-time response to fiber manipulation are among the new features. New studies by prominent researchers and doctors comparing PVP with trans-urethral resection of the prostate (TURP) confirm the significant benefits of PVP for treating an enlarged prostate. These include substantial improvements in safety over TURP as well as safety and effectiveness for a wide variety of patients with special needs, such as those who are fragile, those with large prostate glands, and those being treated with blood-thinning medications. The procedure also lowers healthcare costs.

The new version of GreenLight was introduced at the annual meeting of the American Urological Association in San Antonio (TX, USA) in May 2005. "The outpatient nature of the procedure, combined with a well-demonstrated safety and efficacy profile, is propelling PVP toward the number one position as the treatment of choice for many men around the world exhibiting symptoms of BPH,” noted Eric Reuter, president and CEO of Laserscope (San Jose, CA, USA), which developed the GreenLight laser system.




Related Links:
Laserscope

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.